Seeyond’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.28M Buy
105,152
+18,036
+21% +$225K 0.12% 230
2022
Q3
$1.08M Buy
87,116
+34,499
+66% +$603K 0.13% 241
2022
Q2
$1.03M Sell
52,617
-1,054
-2% -$24.9K 0.12% 301
2022
Q1
$1.4M Buy
53,671
+8,717
+19% +$232K 0.14% 259
2021
Q4
$1.27M Buy
44,954
+13,232
+42% +$412K 0.12% 293
2021
Q3
$1.01M Sell
31,722
-322
-1% -$10.8K 0.1% 335
2021
Q2
$1.11M Buy
32,044
+144
+0.5% +$4.75K 0.1% 293
2021
Q1
$939K Buy
31,900
+12,681
+66% +$390K 0.09% 330
2020
Q4
$589K Buy
19,219
+15,536
+422% +$474K 0.06% 408
2020
Q3
$103K Buy
3,683
+73
+2% +$1.85K 0.01% 583
2020
Q2
$77K Sell
3,610
-96
-3% -$2.12K 0.01% 591
2020
Q1
$330K Sell
3,706
-87
-2% -$2.38K 0.05% 435
2019
Q4
$112K Hold
3,793
0.01% 602
2019
Q3
$101K Hold
3,793
0.01% 607
2019
Q2
$128K Sell
3,793
-19,785
-84% -$642K 0.01% 577
2019
Q1
$756K Buy
+23,578
New +$726K 0.07% 397

Other funds holding ELAN

Seeyond's ELAN Position: Q4 2022 in Review

Seeyond increased its Elanco Animal Health (ELAN) stake by 21% in Q4 2022, buying an estimated $225K and bringing the position to 105,152 shares worth $1.28M. The position accounts for 0.12% of the portfolio, ranked #230.

Seeyond first reported a position in ELAN in Q1 2019 and has held it in 16 quarters since. The position peaked at $1.4M in Q1 2022. 403 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Seeyond held 105,152 shares of Elanco Animal Health worth $1.28M as of Q4 2022.
  • Seeyond bought 18,036 Elanco Animal Health shares in Q4 2022, an estimated $225K.
  • Elanco Animal Health made up 0.12% of Seeyond's portfolio in Q4 2022, its #230 holding.
  • Seeyond first reported a position in Elanco Animal Health in Q1 2019 and has held it in 16 quarters since.
  • Seeyond's Elanco Animal Health position peaked at $1.4M in Q1 2022.
  • 403 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.